Prescient Medicine Holdings, LLC and Metabiomics Corp., have announced a joint venture to develop an innovative microbiome diagnostics platform for detecting precancerous colon polyps and diagnosing other types of gastrointestinal diseases including Crohn’s, colitis (IBD), […]
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance. A scientific paper published in European Journal of Public Health reports that those who take probiotics as […]
Microbiome Insights, Inc. will receive a contribution of up to $190,249 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to help support the development of a new personal health platform […]
The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Azitra, Inc., a company developing microbiome-based therapeutics to treat skin diseases and conditions, have been awarded a $500,000 grant from the Department of Defense (DoD). […]
Ilya Pharma announced that is has now raised an additional Euros 3 million in a new targeted share issue. The funds will facilitate continued growth and take the company through the first clinical study and […]
Optimizing gastrointestinal functionality through balancing feed composition and the microbiota is crucial to efficient feed utilization in poultry farming1. Together with its Alliance partner Novozymes, DSM has created Balancius, a naturally occurring muramidase that removes […]
Califia Farms®, best known for its innovative plant-based beverages in distinctive curvy bottles, accomplished an unprecedented product launch with the introduction of their new line of Probiotic Dairy Free Yogurt Drinks which are already scanning […]
OptiBiotix Health plc (AIM: OPTI) announces that it has entered into a three year non-exclusive licence agreement with Bened Biomedical Ltd., Taiwan (“Bened”). The agreement grants Bened a non-exclusive license to produce, package, promote, market, and […]
EnteroBiotix, a leading clinical stage microbiome therapeutics company, has been granted a manufacturers ‘specials’ license from the Medicines and Healthcare Products Regulatory Agency (MHRA) to further its therapeutic and product pipeline. EnteroBiotix has also appointed […]
Australian life sciences company Bioxyne today announces positive results from its Australian clinical trial into the effects of taking a daily probiotic supplement containing the bacteria strain Lactobacillus fermentum VRI-003, with participants who consumed the […]
Bloom Science and Biose industrie announced today an agreement for the manufacture development of Bloom Science’s novel epilepsy Live Biotherapeutic Product (LBP). Bloom is targeting rare epileptic syndromes with orally-delivered pharmaceutical compositions of specific combined […]